ChromaDex Corporation Common Stock, also called ChromaDex, is a nutraceutical company. The firm engages in acquiring, developing and commercializing proprietary-based ingredient technologies. Read More It operates through the following segments: Ingredients, Consumer Products, and Analytical Reference Standards and Services. The Ingredients segment offers NIAGEN in an ingredient form to partners. The Consumer Products segment sells TRU NIAGEN to improve health by safely raising NAD levels. The Analytical Reference Standards and Services segment provides product regulatory approval and scientific advisory services to the clients in the food, supplement, and pharmaceutical industries. The company was founded by Mark S. Germain and Frank L. Jaksch, Jr. in September 1999 and is headquartered in Los Angeles, CA. The listed name for CDXC is ChromaDex Corporation Common Stock.